INKT earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -3.62. Updated 2026-07-23.
MiNK Therapeutics (INKT) Research Hub
MiNK Therapeutics (INKT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 10.43 USD (-2.61%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.62, market cap 0.05B. This hub links to the full technical, earnings and options research available for INKT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 10.43 USD (-2.61%) |
| 52-week range | 9.19 USD – 12.98 USD |
| Trend regime | Range |
| 14-day RSI | 37.9 (Bearish) |
| Trailing P/E | -3.62 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for INKT
Covered Call on INKT: how it works, illustrative setup around the real 10.43 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INKT: how it works, illustrative setup around the real 10.43 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INKT: how it works, illustrative setup around the real 10.43 USD price, max profit/loss, breakeven and when to use it. Educational.
INKT technical analysis: range, last 10.43 USD, RSI 37.9, 52w range 9.19 USD–12.98 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is INKT in?
MiNK Therapeutics (INKT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INKT in an uptrend or downtrend?
As of 2026-10-26, INKT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INKT's trailing P/E ratio?
INKT's trailing P/E is -3.62, with a market cap of 0.05B. See the earnings research page for full valuation detail.
When does INKT next report earnings?
INKT is next scheduled to report earnings on 2026-08-13.